Topical Menthol For Tear Secretion

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 17, 2025

Primary Completion Date

November 7, 2025

Study Completion Date

December 1, 2025

Conditions
HealthyDry Eyes
Interventions
DRUG

Topical application of 20% menthol solution in MCT oil.

To facilitate reproducible and correct application of the solution, the subject wears glasses while the product is applied. The solution is rolled onto one cheek by rolling it to an area of about 2cm X 2cm at the cheekbone, underneath the bottom rim of the glasses worn. This method delivers about 12 mg solution, i.e. 2.4 mg menthol to one cheek. Or this method delviers 12 mg of placebo oil. The subject then sits in still air for 5 minutes, at which point tissue is wiped across the skin below the bottom eyelashes to permit the weighing of secreted tear.

DRUG

Topical Placebo Oil rolled onto the cheek.

To facilitate reproducible and correct application of the Placebo oil, the subject wears glasses while the product is applied. The Placebo oil is rolled onto one cheek by rolling it to an area of about 2cm X 2cm at the cheekbone, underneath the bottom rim of the glasses worn. This method delivers zero active agent. The subject then sits in still air for 5 minutes, at which point tissue is wiped across the skin below the bottom eyelashes to permit the weighing of secreted tear.

Trial Locations (1)

M4K1X4

Stearacl Incorporated., Toronto

All Listed Sponsors
collaborator

Stearacl Inc

INDUSTRY

lead

Reinhold Vieth

INDUSTRY